enalaprilat - CISMeF

Preferred Label : enalaprilat;

MeSH definition : The active metabolite of ENALAPRIL and a potent intravenously administered angiotensin-converting enzyme inhibitor. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.; The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.;

CISMeF synonym : 76420-72-9 (Enalaprilat anhydrous); enalaprilat dihydrate; enalapril TEVA; EnalaprilTEVA; boehringer ingelheim brand of enalaprilat anhydrous; teva brand of enalaprilat; biovail brand of enalaprilat anhydrous; merck frosst brand of enalaprilat anhydrous; MSD brand of enalaprilat; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate; anhydrous enalaprilat citrate; anhydrous, enalaprilat; dihydrate, enalaprilat; enalaprilic acid;

DeCS synonym : Enalaprilat Dihydrate;

MeSH hyponym : enalaprilat citrate, anhydrous; enalaprilat, (R)-Isomer, anhydrous; xanef; pres iv; Enalapril-TEVA; enalaprilat anhydrous; MK-422; vasotec; MK 422; MK422;

MeSH CAS label : L-Proline, 1-(N-(1-carboxy-3-phenylpropyl)-L-alanyl)-, dihydrate, (S)-; L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-;

MeSH Related Number : enalaprilat anhydrous; enalaprilat, (R)-Isomer, anhydrous; enalaprilat citrate, anhydrous; 76391-23-6 ((R)-isomer, anhydrous); 84680-54-6 (Enalaprilat); 84799-87-1 (cpd w/o stereochem designation, anhydrous); 94133-18-3 (anhydrous, citrate); Q508Q118JM;

Registry Number MeSH : 84680-54-6;

Related CAS MeSH : 76391-23-6 (Enalaprilat, (R)-Isomer, anhydrous); 94133-18-3 (Enalaprilat citrate, anhydrous); Q508Q118JM (Enalaprilat anhydrous);

Wikipedia link : https://en.wikipedia.org/wiki/Enalaprilat;

Codes EINECS : 278-459-3;

Is substance : O;

UNII : GV0O7ES0R3;

InChIKey : MZYVOFLIPYDBGD-MLZQUWKJSA-N;

Details

Origin ID

D015773;

UMLS CUI

C0014027;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Enalaprilat [ICHI extension code]
- Enalaprilat Anhydrous [NCIt concept]
Fils d'après SNOMED CT
- angiotensin-converting enzyme inhibitors [MeSH Descriptor]
Pharmacological action(s)
- angiotensin-converting enzyme inhibitors [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
Record concept(s)
- 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate [MeSH concept]
- Enalaprilat Dihydrate [MeSH concept]
- Enalaprilic Acid [MeSH concept]
- MK-422 [MeSH concept]
- enalaprilat [MeSH concept]
- enalaprilat anhydrous [MeSH concept]
- enalaprilat citrate, anhydrous [MeSH concept]
- enalaprilat, (R)-Isomer, anhydrous [MeSH concept]
- pres iv [MeSH concept]
- vasotec [MeSH concept]
- xanef [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients